Fair Isaac told the SEC it will cut about 15% of positions companywide, citing fewer management layers, a simpler structure and AI-driven product development. Employees began receiving notice the week of October 5.
Foghorn Therapeutics plans to cut about 40% of its workforce, leaving about 65 full-time employees, after it and Eli Lilly decided not to advance FHD-909 into the expansion phase, according to an Oct. 1 SEC filing.
AI-computing company Blaize disclosed in an SEC filing that it is carrying out a restructuring that includes a reduction in force affecting about 26% of its employees, with expected annual savings of $7.5 million to $8.4 million.
